Ceribell, Inc. (CBLL) stock
CBLLNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 6/30150% above fair value
$26.35−1.45 (-5.22%)
Close on Nov 12, 2026Market cap $1.01BP/E –Yield –
Ceribell operating margin
Operating margin is operating income as a percentage of revenue.
Ceribell's operating margin for the twelve months ending Jun 30, 2026 was -68.6%. For fiscal 2025 it was -65.6%, against -60.7% the year before.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -65.6% | −4.9 |
| FY2024 | Dec 31, 2024 | -60.7% | +5.7 |
| FY2023 | Dec 31, 2023 | -66.4% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -71.1% | −0.6 |
| Q1 FY2026 | Mar 31, 2026 | -78.3% | −9.0 |
| Q4 FY2025 | Dec 31, 2025 | -58.9% | +10.6 |
| Q3 FY2025 | Sep 30, 2025 | -64.8% | −7.1 |
| Q2 FY2025 | Jun 30, 2025 | -70.5% | −15.5 |
| Q1 FY2025 | Mar 31, 2025 | -69.3% | −10.6 |
| Q4 FY2024 | Dec 31, 2024 | -69.5% | −5.7 |
| Q3 FY2024 | Sep 30, 2024 | -57.8% | +3.9 |
| Q2 FY2024 | Jun 30, 2024 | -55.1% | – |
| Q1 FY2024 | Mar 31, 2024 | -58.7% | – |
| Q4 FY2023 | Dec 31, 2023 | -63.8% | – |
| Q3 FY2023 | Sep 30, 2023 | -61.7% | – |
See a number that looks wrong?